R Arora Selected Research

R Arora Research Topics

Disease

7	Neoplasms (Cancer) 10/2019 - 08/2004
4	Infections 10/2018 - 06/2005
3	Wounds and Injuries (Trauma) 10/2018 - 04/2008
3	Diarrhea 06/2012 - 01/2006
2	Burns 10/2018 - 03/2005
2	Necrosis 10/2018 - 08/2015
2	Hemorrhage 10/2018 - 08/2007
2	Arthritis (Polyarthritis) 06/2017 - 08/2015
2	Dupuytren Contracture (Dupuytrens Contracture) 04/2017 - 02/2016
2	Tuberculosis (Tuberculoses) 01/2011 - 09/2002
2	Pain (Aches) 06/2007 - 05/2005
2	Papillomavirus Infections 11/2006 - 09/2005
2	Hepatitis 06/2005 - 04/2005
2	Myocardial Infarction 10/2004 - 05/2000
1	Bacterial Infections (Bacterial Infection) 11/2022
1	Myocarditis (Carditis) 06/2022
1	Colorectal Neoplasms (Colorectal Cancer) 10/2019
1	Open Fractures (Compound Fracture) 10/2018
1	Hemorrhagic Cystitis 05/2017
1	Hyperplasia 04/2017
1	Suppurative Otitis Media 08/2016
1	Hypersensitivity (Allergy) 02/2016
1	Mucopolysaccharidoses 04/2014
1	Obesity 01/2014
1	Placenta Accreta 10/2013
1	Granular Cell Tumor 07/2013
1	Dental Fluorosis 10/2012
1	Smear Layer 08/2012
1	Rotavirus Infections 06/2012
1	Gastroenteritis 06/2012
1	Vision Disorders (Hemeralopia) 09/2011
1	Posterior Leukoencephalopathy Syndrome 08/2011
1	Ischemic Stroke 06/2011
1	Nephrogenic Fibrosing Dermopathy 06/2011
1	Bronchiectasis 01/2011
1	Lung Diseases (Lung Disease) 01/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2010

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 10/2019 - 06/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2018 - 01/2008
2	Microbial Collagenase (Clostridiopeptidase A)FDA Link 04/2017 - 02/2016
2	Collagenases (Collagenase)FDA Link 04/2017 - 02/2016
2	Methotrexate (Mexate)FDA LinkGeneric 10/2013 - 08/2011
2	VaccinesIBA 06/2012 - 08/2010
2	Cisplatin (Platino)FDA LinkGeneric 10/2009 - 07/2005
2	Pain-FreeIBA 06/2007 - 05/2005
2	AcidsIBA 03/2005 - 12/2000
1	AmidesIBA 11/2022
1	MineralsIBA 11/2022
1	CarbonatesIBA 11/2022
1	Phosphates (Orthophosphate)IBA 11/2022
1	ParaffinIBA 06/2022
1	Formaldehyde (Formol)FDA Link 06/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2019
1	Cefuroxime (Zinacef)FDA LinkGeneric 10/2018
1	Second Generation CephalosporinsIBA 10/2018
1	Cidofovir (Vistide)FDA Link 05/2017
1	CollagenIBA 04/2017
1	Excipients (Suspending Agents)IBA 02/2016
1	AnticoagulantsIBA 02/2016
1	C-Reactive ProteinIBA 08/2015
1	Freund's AdjuvantIBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	cyclic citrullinated peptideIBA 08/2015
1	CurcuminIBA 08/2015
1	Lipid NanoparticlesIBA 08/2015
1	Phosphotransferases (Kinase)IBA 05/2015
1	MicroRNAs (MicroRNA)IBA 05/2015
1	CarbohydratesIBA 01/2014
1	Periodic AcidIBA 07/2013
1	Amylases FDA Link 07/2013
1	FluoridesIBA 10/2012
1	chemotactic factor inactivatorIBA 10/2012
1	Drinking WaterIBA 10/2012
1	Calcium HydroxideIBA 08/2012
1	PapacarieIBA 08/2012
1	Rotavirus VaccinesIBA 06/2012
1	Retinaldehyde (Retinal)IBA 09/2011
1	reteplase FDA Link 06/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2011
1	GadoliniumIBA 06/2011
1	Contrast MediaIBA 06/2011
1	Adrenergic Receptors (Adrenergic Receptor)IBA 12/2010

Therapy/Procedure

7	Therapeutics 10/2019 - 05/2001
3	Stents 08/2002 - 05/2000
2	Surgical Amputation (Amputations) 10/2018 - 08/2009
2	Arthrodesis 06/2017 - 11/2010
2	Injections 04/2017 - 02/2016
2	Corneal Transplantation (Keratoplasty) 04/2014 - 08/2005
2	Hysterectomy 10/2013 - 01/2010
2	Catheters 10/2010 - 04/2001
2	Radiofrequency Ablation 08/2001 - 09/2000
1	Contraindications 10/2018
1	Antibiotic Prophylaxis 10/2018
1	Debridement 10/2018
1	Negative-Pressure Wound Therapy 10/2018
1	Second-Look Surgery 10/2018
1	Hematopoietic Stem Cell Transplantation 05/2017
1	Tympanoplasty 08/2016
1	Conservative Treatment 10/2013
1	Pneumonectomy (Lung Volume Reduction) 01/2011